Piyavit from the Medicinal Leech Is a New Orally Active Anticoagulating and Antithrombotic Drug

Piyavit, a novel pharmacological preparation allowed in Russia as an oral antithrombotic drug for clinical use, contains medicinal leech saliva as the main source of biologically active substances that inhibit platelet-vascular and plasmic hemostasis and provide thrombolysis. It is shown that piyavit administered orally or subcutaneously to animals inhibits arterial thrombus formation. In 22 patients with acquired heart valvular disease after implantation of a cardiac artificial valve who received oral piyavit capsules and phenilin 2-3 days after the operation, blood hypercoagulability was reduced in comparison to that of 20 patients after the same type of operation who received only phenilin. An antiinflammatory effect and decreased blood hypercoagulability were observed in 38 patients with thrombophlebitis of the greater saphenous vein who received the same piyavit capsules orally. The results confirm that piyavit as an oral anticoagulant and antithrombotic drug may be an alternative to known antithrombotic preparations. Key Words: Anticoagulation—Antithrombotic drug—Leech saliva— Medicinal leech-Piyavit.

[1]  D. Callas,et al.  Comparative Pharmacology of Site Directed Antithrombin Agents. Implication in Drug Development , 1995, Thrombosis and Haemostasis.

[2]  D. Hoppensteadt,et al.  Section Review—Cardiovascular & Renal: Recent Developments in Antithrombotic Agents , 1995 .

[3]  I. Baskova,et al.  Piyavit ― a complex preparation from the medicinal leech improves blood rheology and decreases platelet aggregation , 1995 .

[4]  E. Topol,et al.  Use of A Direct Antithrombin, Hirulog, in Place of Heparin During Coronary Angioplast , 1993, Circulation.

[5]  H. Vinazzer,et al.  The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits. , 1993, Thrombosis research.

[6]  C. Doutremépuich,et al.  Effects of aspirin on embolization in an arterial model of laser-induced thrombus formation. , 1993, Haemostasis.

[7]  I. Baskova,et al.  Inhibition of plasma kallikrein. Kininase and kinin-like activities of preparations from the medicinal leeches. , 1992, Thrombosis research.

[8]  A. Eldor,et al.  A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. , 1992, Prostaglandins.

[9]  I. Baskova,et al.  Use of the medicinal leech in the treatment of ear diseases. , 1992, ORL; journal for oto-rhino-laryngology and its related specialties.

[10]  I. Baskova,et al.  Destabilase, the novel epsilon-(gamma-Glu)-Lys isopeptidase with thrombolytic activity. , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[11]  S. Adams,et al.  The medicinal leech. A page from the annelids of internal medicine. , 1988, Annals of internal medicine.

[12]  I. Baskova,et al.  Antithrombotic effect of preparations from the leeches Hirudo medicinalis. , 1988, Folia haematologica.

[13]  I. Baskova,et al.  [Mechanisms of inhibition of vascular-platelet hemostasis by salivary gland secretion of the medicinal leech Hirudo medicinalis]. , 1987, Biokhimiia.

[14]  J. Upton,et al.  Microsurgical Reattachment of Totally Amputated Ears , 1987, Plastic and reconstructive surgery.

[15]  D. McRee,et al.  Blood volume recovery in hemorrhaged Japanese quail. , 1987, Comparative biochemistry and physiology. A, Comparative physiology.

[16]  A. Eldor,et al.  The saliva of the medicinal leech Hirudo medicinalis--II. Inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects. , 1987, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[17]  H. Levy,et al.  The saliva of the medicinal leech Hirudo medicinalis--I. Biochemical characterization of the high molecular weight fraction. , 1987, Comparative biochemistry and physiology. B, Comparative biochemistry.

[18]  J. Cazenave,et al.  Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Baskova Ip,et al.  [Destabilase: an enzyme of medicinal leech salivary gland secretion hydrolyzes the isopeptide bonds in stabilized fibrin]. , 1985 .

[20]  F. Markwardt.  Pharmacology of hirudin: one hundred years after the first report of the anticoagulant agent in medicinal leeches. , 1985, Biomedica biochimica acta.

[21]  Iusupova Gi,et al.  [Lipase and cholesterol-esterase activity in the salivary gland secretions of the medical leech Hirudo medicinalis]. , 1984 .

[22]  T. Paskhina,et al.  [Uniform method for determining the alpha 1-antitrypsin and alpha 2-macroglobulin activity in human blood serum (plasma)]. , 1979, Voprosy meditsinskoi khimii.

[23]  M. Blombäck,et al.  Substrates for determination of trypsin, thrombin and thrombin-like enzymes. , 1972, Folia haematologica.

[24]  S. Chlubek.  [Fibrinogen determination]. , 1972, Wiadomosci lekarskie.

[25]  U. Abildgaard,et al.  Assay of Progressive Antithrombin in Plasma , 1970, Thrombosis and Haemostasis.

[26]  G. Born,et al.  The aggregation of blood platelets , 1963, The Journal of physiology.

[27]  A. Quick.  Clinical Interpretation of the One‐Stage Prothrombin Time , 1961, Circulation.